FDA
approval
· 2022-12-16
FDA Approved: TADALAFIL — Supplemental Application (AvKARE)
Summary
FDA supplemental approval for tadalafil from AvKARE (ANDA210608).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TADALAFIL (TADALAFIL)